RT Journal Article
SR Electronic
T1 Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003190
DO 10.1136/jitc-2021-003190
VO 10
IS 1
A1 Rob, Lukas
A1 Cibula, David
A1 Knapp, Pawel
A1 Mallmann, Peter
A1 Klat, Jaroslav
A1 Minar, Lubos
A1 Bartos, Pavel
A1 Chovanec, Josef
A1 Valha, Petr
A1 Pluta, Marek
A1 Novotny, Zdenek
A1 Spacek, Jiri
A1 Melichar, Bohuslav
A1 Kieszko, Dariusz
A1 Fucikova, Jitka
A1 Hrnciarova, Tereza
A1 Korolkiewicz, Roman Pawel
A1 Hraska, Marek
A1 Bartunkova, Jirina
A1 Spisek, Radek
YR 2022
UL http://jitc.bmj.com/content/10/1/e003190.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.